Clinical & Translational Pilot Awards Program

The overall goal of the Clinical and Translational Pilot Awards Program is to provide seed funding to facilitate new research and future funding. Multidisciplinary research is strongly encouraged, as well as translational and clinical research that moves new discoveries along the translational continuum to humans and the community. Clinical and community based research, practice-based research, and health services research proposals are also encouraged. Click here to view information about past awardees and their projects.The Pilot Program currently offers five different categories of funding:

Investigator-intitated Pilot Studies for Faculty

The primary goal of support provided in the Faculty category is to provide the groundwork for faculty to obtain subsequent funding. In addition, there is an expectation that the support provided by the CTSI will result in academic productivity inpublication of the research. A maximum of $50,000 will be awarded for a period of one year.

Investigator-initiated Pilot Studies for Trainees

The primary goal of support provided in the Trainee category is for the trainee to obtain the most prestigious fellowship and subsequently to becomean independent investigator. The latter isa longer-term goal that strengthensand complements the strategic goals of the University and Medical Center. A maximum of $25,000 will be awarded for a period of one year.

UNYTE Translational Research Network Grants

The primary goal of UNYTE Translational Research Network award category is to stimulate new inter-institutional collaborations in health research. Investigators are encouraged to develop an innovative, team-based approach to a problem in health research that reflects the particular strengths UNYTE members and their institutions. Learn more about the UNYTE Translational Research Network here. A maximum of $50,000 will be awarded for a period of one year.

Clinical Trials Methods and Technologies Grants

The primary goal of the Clinical Trials Methods and Technologies award category is to develop and / or evaluate new methods and technologies for use in clinical trials. A maximum of $50,000 will be awarded for a period of one year.

Novel Biostatistical and Epidemiologic Methods Awards

The primary goal of the Novel Biostatistical and Epidemiologic Methods award category is to stimulate the development of novel biostatistical and epidemiologic methods that help overcome specifically identified limitations and significantly enhance the validity and accuracy, scope or speed of clinical or translational research.A maximum of $35,000 will be awarded for a 1 year period. Strong proposals spanning two years will be considered on a case by case basis Click here to read more about this program.

Request for Applications

The 2014 RFA is closed, click here to view the closed RFA. The 2015 Request for Applications is expected to be released in July 2015.

PI Attestation

All applications require a signed attestation from the PI that the project is not funded through another mechanism. Click here for a template for the PI attestation. If you have trouble accessing the submission system using the link in the RFA, please click here to apply.

Eligible Research

The NIH institute funding the CTSI (the National Center for Advancing Translational Sciences, or NCATS), can only support clinical trials through Phase 2a; therefore projects that involve Phase 2b clinical trials or higher are not eligible for the CTSI pilot project program. 

Review Priorities

Priorities for awarding pilot funding are as follows:

  • Faculty Category–Proposals with the bestpotential to receive subsequent R01 or other grant funding will receive the highest priority for funding.
  • Trainee Category–Proposals that are the most likely to be competitive for subsequent funding through the NIH’s Fellowship or K mechanism will receive the highest priority for funding.
  • UNYTE Category–In addition to review priorities for the Faculty Category, proposals that involve meaningful participation of faculty and facilities from the UR and at least one other UNYTE member institution.
  • Clinical Trials Methods and Technologies Category–In addition to the review priorities for the Faculty and Trainee Categories, impact on the future conduct of clinical trials.

Review Process

The 1 page abstracts are reviewed and scored by the CTSI review committee, a standing faculty committee. After a face-to-face review meeting, approximately 1/4 to 1/3 of the proposals are selected for solicitation of full proposals. Full proposals, which consist of 6-page grant applications in NIH format, are reviewed by the CTSI review committee and other selected adhoc experts which subject the proposals to rigorous scientific review. Following the review process and a formal study section-style discussion and scoring meeting, funding recommendations are made to the CTSI Operations Committee for funding of the most meritorious projects.

 

NIH Funding Acknowledgement ** Important ** All publications resulting from the utilization of CTSI resources are required to credit the CTSI grant by including the NIH FUNDING ACKNOWLEDGEMENT and must comply with the NIH Public Access Policy.